ATE213644T1 - Kombinationstherapie für die behandlung von arthritis erkrankungen - Google Patents

Kombinationstherapie für die behandlung von arthritis erkrankungen

Info

Publication number
ATE213644T1
ATE213644T1 AT97942106T AT97942106T ATE213644T1 AT E213644 T1 ATE213644 T1 AT E213644T1 AT 97942106 T AT97942106 T AT 97942106T AT 97942106 T AT97942106 T AT 97942106T AT E213644 T1 ATE213644 T1 AT E213644T1
Authority
AT
Austria
Prior art keywords
combination therapy
treatment
arthritis diseases
diseases
arthritis
Prior art date
Application number
AT97942106T
Other languages
English (en)
Inventor
Lars Michael Wood
David Olum Laber
Annette Wright
Original Assignee
British Biotech Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharm filed Critical British Biotech Pharm
Application granted granted Critical
Publication of ATE213644T1 publication Critical patent/ATE213644T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
AT97942106T 1996-09-20 1997-09-18 Kombinationstherapie für die behandlung von arthritis erkrankungen ATE213644T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9619631.6A GB9619631D0 (en) 1996-09-20 1996-09-20 Combination therapy
PCT/GB1997/002604 WO1998011908A1 (en) 1996-09-20 1997-09-18 Combination therapy for treatment of arthritic diseases

Publications (1)

Publication Number Publication Date
ATE213644T1 true ATE213644T1 (de) 2002-03-15

Family

ID=10800216

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97942106T ATE213644T1 (de) 1996-09-20 1997-09-18 Kombinationstherapie für die behandlung von arthritis erkrankungen

Country Status (7)

Country Link
EP (1) EP0936918B1 (de)
JP (1) JP2001500873A (de)
AT (1) ATE213644T1 (de)
AU (1) AU4390597A (de)
DE (1) DE69710752D1 (de)
GB (1) GB9619631D0 (de)
WO (1) WO1998011908A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP584198A0 (en) * 1998-09-14 1998-10-08 Fujisawa Pharmaceutical Co., Ltd. New use
MX368013B (es) 2001-02-19 2019-09-13 Novartis Ag Tratamiento de cáncer.
TW200509958A (en) * 2003-02-14 2005-03-16 Combinatorx Inc Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU671724B2 (en) * 1993-03-16 1996-09-05 British Biotech Pharmaceuticals Limited Hydroxamic acid derivatives as metalloproteinase inhibitors

Also Published As

Publication number Publication date
EP0936918B1 (de) 2002-02-27
DE69710752D1 (de) 2002-04-04
EP0936918A1 (de) 1999-08-25
GB9619631D0 (en) 1996-11-06
WO1998011908A1 (en) 1998-03-26
AU4390597A (en) 1998-04-14
JP2001500873A (ja) 2001-01-23

Similar Documents

Publication Publication Date Title
DE69718731D1 (de) Kombinationstherapie für die Behandlung von Psychosen
DE69905938D1 (de) Kombination von duloxetin mit nichtsteroid-entzündungshemmern für die behandlung von schmerz
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
DE69927823T2 (de) Hydrogel für die therapeutische behandlung von aneurysmas
ATE301457T1 (de) Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
BG101717A (bg) Инхибитори на микрозомалния триглицерид пренасящ белтък и метод
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
NZ335981A (en) Ketobenzamides as calpain inhibitors
ATE315390T1 (de) Zyklische polyamine zur behandlung der thrombozytopenie
TR200200673T2 (tr) Rinovirüs enfeksiyonlarında csaıd'lerin kullanılması
DE69630539D1 (de) Zweistufiges system für die neutralisation von iod bei der behandlung von kontaktlinsen
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
DE69423533D1 (de) Zubereitungen zur Behandlung von Impotenz, die ein Alpha-1 inhibitor und ein Alpha-2 inhibitor enthalten
EP0758021A3 (de) Verfahren zur Bestimmung der therapeutischen Wirkung von Metalloproteinase-Verbindungen, neue Inhibitor-Verbindungen und deren therapeutische Verwendung
DE69825733D1 (de) Spezifische inhibitoren der pankreatischen lipase und deren anwendungen
ATE213644T1 (de) Kombinationstherapie für die behandlung von arthritis erkrankungen
ATE254595T1 (de) 2-amino-6-methyl-7-acetyl-tetralin und pharmazeutische zusammensetzungen zur vorbeugung und therapeutischen behandlung von entzündlichen und/oder autoimmunkrankheiten
DE69736180D1 (de) Behandlung von manischen erkrankungen
DE69930844D1 (de) Inhibitoren von mycobakterien
DE59813914D1 (de) Mittel zur behandlung und/oder prophylaxe von mikrozirkulationsstörungen
ID27052A (id) Pengobatan arthritis dan keadaan-keadaan lain yang sekupa
ATE360425T1 (de) Verwendung von quetiapin für die behandlung von kokain-abhängigkeit
UA26939C2 (uk) Засіб для лікуваhhя аутоімуhhих захворюваhь і спосіб їх лікуваhhя
ATE365718T1 (de) Substituierte 11-phenyl-dibenzazepin-verbindungen,die nützlich sind zur behandlung oder vorbeugung von durch abnormale zellproliferation gekennzeichneten krankheiten
NO984198L (no) FremgangsmÕte for behandling av aggresjon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties